• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖对心房颤动消融的影响。

Impact of obesity on atrial fibrillation ablation.

机构信息

Department of Cardiovascular, Respiratory, Nephrological, Anaesthesiological and Geriatric Sciences, "Sapienza" University of Rome, Policlinico Umberto I, 00161 Rome, Italy.

Barts Heart Centre, West Smithfield, London EC1A 7BE, United Kingdom.

出版信息

Arch Cardiovasc Dis. 2020 Aug-Sep;113(8-9):551-563. doi: 10.1016/j.acvd.2020.03.023. Epub 2020 Aug 1.

DOI:10.1016/j.acvd.2020.03.023
PMID:32753124
Abstract

Obesity is a major risk factor for atrial fibrillation. It also influences the natural history of the disease, leading to more persistent forms and poorer ablation outcomes. This article reviews atrial fibrillation ablation in the obese population, focusing on outcomes, complications and periprocedural management. Through an analysis of the possible pathophysiological mechanism linking obesity and atrial fibrillation, we identify potential strategies to improve post-ablation outcomes in this challenging population.

摘要

肥胖是心房颤动的一个主要危险因素。它还影响疾病的自然病程,导致更持续的形式和更差的消融结果。本文回顾了肥胖人群中的心房颤动消融,重点关注结局、并发症和围手术期管理。通过分析肥胖和心房颤动之间可能的病理生理机制,我们确定了一些潜在的策略,以改善这一具有挑战性人群的消融后结局。

相似文献

1
Impact of obesity on atrial fibrillation ablation.肥胖对心房颤动消融的影响。
Arch Cardiovasc Dis. 2020 Aug-Sep;113(8-9):551-563. doi: 10.1016/j.acvd.2020.03.023. Epub 2020 Aug 1.
2
Impact of obesity on atrial fibrillation ablation: Patient characteristics, long-term outcomes, and complications.肥胖对心房颤动消融的影响:患者特征、长期结局及并发症
Heart Rhythm. 2017 Jun;14(6):819-827. doi: 10.1016/j.hrthm.2017.02.023. Epub 2017 Feb 20.
3
Catheter ablation of atrial fibrillation in "very severe" obese patients (BMI ≥ 40): Insights from "the ICE-Obese Extreme" study.“极度肥胖”患者(BMI≥40)心房颤动的导管消融:来自“ICE-肥胖极端”研究的见解。
J Cardiovasc Electrophysiol. 2024 Aug;35(8):1711-1713. doi: 10.1111/jce.16361. Epub 2024 Jul 4.
4
Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.超重和肥胖患者行肺静脉隔离术后心房颤动复发率增加。
J Cardiovasc Electrophysiol. 2018 Feb;29(2):239-245. doi: 10.1111/jce.13388. Epub 2017 Dec 14.
5
Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials.当代心房颤动消融随机对照试验中肥胖的代表性。
J Cardiovasc Electrophysiol. 2024 Oct;35(10):2006-2016. doi: 10.1111/jce.16396. Epub 2024 Aug 13.
6
Heterogeneity in Conduction Underlies Obesity-Related Atrial Fibrillation Vulnerability.传导异质性是肥胖相关心房颤动易感性的基础。
Circ Arrhythm Electrophysiol. 2020 May;13(5):e008161. doi: 10.1161/CIRCEP.119.008161. Epub 2020 Apr 17.
7
Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study.肥胖伴心房颤动患者的心肺适能对心律失常复发的影响:CARDIO-FIT 研究。
J Am Coll Cardiol. 2015 Sep 1;66(9):985-96. doi: 10.1016/j.jacc.2015.06.488. Epub 2015 Jun 22.
8
Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue.肥胖和糖尿病合并心房颤动患者管理中的疾病-治疗相互作用:心外膜脂肪组织的潜在中介影响。
Cardiovasc Diabetol. 2019 Sep 24;18(1):121. doi: 10.1186/s12933-019-0927-9.
9
Outcomes of Atrial Fibrillation Ablation in Morbidly Obese Patients Following Bariatric Surgery Compared With a Nonobese Cohort.肥胖症患者行减重手术后与非肥胖患者行房颤消融术的结局比较。
Circ Arrhythm Electrophysiol. 2019 Oct;12(10):e007598. doi: 10.1161/CIRCEP.119.007598. Epub 2019 Oct 15.
10
Catheter Ablation for Long-Standing Persistent Atrial Fibrillation.长期持续性心房颤动的导管消融治疗
Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):87-93. doi: 10.14797/mdcj-11-2-87.

引用本文的文献

1
Cryoballoon Pulmonary Vein Isolation in Obese Patients with Atrial Fibrillation Compared to Non-Obese Counterparts: A Meta-Analysis.肥胖房颤患者与非肥胖患者相比,冷冻球囊肺静脉隔离术的Meta分析
Biomedicines. 2025 Jan 25;13(2):298. doi: 10.3390/biomedicines13020298.
2
Risk and Protective Factors of Recurrence after Catheter Ablation for Atrial Fibrillation.心房颤动导管消融术后复发的危险因素与保护因素
Rev Cardiovasc Med. 2024 Mar 1;25(3):81. doi: 10.31083/j.rcm2503081. eCollection 2024 Mar.
3
Impact of Obesity on Atrial Electrophysiological Substrate.
肥胖对心房电生理基质的影响。
J Cardiovasc Dev Dis. 2023 Aug 8;10(8):342. doi: 10.3390/jcdd10080342.
4
Effectiveness and Safety of Idarucizumab for Periprocedural Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation in Dabigatran Recipients: A Retrospective Controlled Study.达比加群酯治疗患者经导管消融心房颤动围术期心脏压塞的有效性和安全性:一项回顾性对照研究。
Am J Cardiovasc Drugs. 2022 Sep;22(5):557-565. doi: 10.1007/s40256-022-00536-7. Epub 2022 Jun 18.
5
Adipose Tissue Inflammation and Cardiovascular Disease: An Update.脂肪组织炎症与心血管疾病:最新进展
Curr Diab Rep. 2022 Jan;22(1):27-37. doi: 10.1007/s11892-021-01446-9. Epub 2022 Feb 18.
6
New Insights on the Role of Connexins and Gap Junctions Channels in Adipose Tissue and Obesity.关于连接蛋白和缝隙连接通道在脂肪组织和肥胖中的作用的新见解。
Int J Mol Sci. 2021 Nov 10;22(22):12145. doi: 10.3390/ijms222212145.